30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
18 Oct 2024
// FDA
01 2Levobunolol hydrochloride
02 2Tazarotene
01 2GEL
02 2OPD
01 11mg/g
02 35mg/ml
01 2Betagan 0.5% Liquifilm
02 1Zorac 0,05%
03 1Zorac 0,1%
Regulatory Info : Originator
Registration Country : South Africa
Dosage Form : OPD
Dosage Strength : 5mg/ml
Packaging : 5X1mg/ml
Brand Name : Betagan 0.5% Liquifilm
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Dosage Form : OPD
Dosage Strength : 5mg/ml
Packaging : 7.5X1mg/ml
Brand Name : Betagan 0.5% Liquifilm
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Dosage Form : GEL
Dosage Strength : 5mg/ml
Packaging : 30X1mg/ml
Brand Name : Zorac 0,05%
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Dosage Form : GEL
Dosage Strength : 1mg/g
Packaging : 30X1mg/g
Brand Name : Zorac 0,1%
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
LOOKING FOR A SUPPLIER?